世界の子宮内膜症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Endometriosis Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2159
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、90ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、子宮内膜症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ホルモン避妊薬、ゴナドトロピン放出ホルモン（Gn-RH）アゴニスト、プロゲスチン療法、アロマターゼ阻害剤）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・子宮内膜症治療の市場動向
・企業の競争状況、市場シェア
・子宮内膜症治療の種類別市場規模（ホルモン避妊薬、ゴナドトロピン放出ホルモン（Gn-RH）アゴニスト、プロゲスチン療法、アロマターゼ阻害剤）
・子宮内膜症治療の用途別市場規模（病院、クリニック、その他）
・子宮内膜症治療の北米市場規模2016-2027（アメリカ、カナダ）
・子宮内膜症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・子宮内膜症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・子宮内膜症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・子宮内膜症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（AbbVie、Eli Lilly、AstraZeneca、Bayer、Astellas Pharma、Meditrina Pharmaceuticals、Pfizer、Neurocrine Biosciences、Takeda Pharmaceutical）
・結論

Therapies used to treat endometriosis include: Hormonal contraceptives. Birth control pills, patches and vaginal rings help control the hormones responsible for the buildup of endometrialtissue each month

Market Analysis and Insights: Global Endometriosis Treatment Market
The global Endometriosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Endometriosis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Endometriosis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Endometriosis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Endometriosis Treatment market.

Global Endometriosis Treatment Scope and Market Size
Endometriosis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Endometriosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Hormonal Contraceptives
Gonadotropin-releasingHormone(Gn-RH)Agonists
Progestin Therapy
Aromatase Inhibitors

Segment by Application
Hospital
Clinic
Other

By Region
North America
the United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AbbVie
Eli Lilly
AstraZeneca
Bayer
Astellas Pharma
Meditrina Pharmaceuticals
Pfizer
Neurocrine Biosciences
Takeda Pharmaceutical

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endometriosis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hormonal Contraceptives
1.2.3 Gonadotropin-releasingHormone(Gn-RH)Agonists
1.2.4 Progestin Therapy
1.2.5 Aromatase Inhibitors
1.3 Market by Application
1.3.1 Global Endometriosis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Endometriosis Treatment Market Perspective (2016-2027)
2.2 Endometriosis Treatment Growth Trends by Regions
2.2.1 Endometriosis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Endometriosis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Endometriosis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Endometriosis Treatment Industry Dynamic
2.3.1 Endometriosis Treatment Market Trends
2.3.2 Endometriosis Treatment Market Drivers
2.3.3 Endometriosis Treatment Market Challenges
2.3.4 Endometriosis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Endometriosis Treatment Players by Revenue
3.1.1 Global Top Endometriosis Treatment Players by Revenue (2016-2021)
3.1.2 Global Endometriosis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Endometriosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Endometriosis Treatment Revenue
3.4 Global Endometriosis Treatment Market Concentration Ratio
3.4.1 Global Endometriosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endometriosis Treatment Revenue in 2020
3.5 Endometriosis Treatment Key Players Head office and Area Served
3.6 Key Players Endometriosis Treatment Product Solution and Service
3.7 Date of Enter into Endometriosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Endometriosis Treatment Breakdown Data by Type
4.1 Global Endometriosis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Endometriosis Treatment Forecasted Market Size by Type (2022-2027)

5 Endometriosis Treatment Breakdown Data by Application
5.1 Global Endometriosis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Endometriosis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Endometriosis Treatment Market Size (2016-2027)
6.2 North America Endometriosis Treatment Market Size by Type
6.2.1 North America Endometriosis Treatment Market Size by Type (2016-2021)
6.2.2 North America Endometriosis Treatment Market Size by Type (2022-2027)
6.2.3 North America Endometriosis Treatment Market Size by Type (2016-2027)
6.3 North America Endometriosis Treatment Market Size by Application
6.3.1 North America Endometriosis Treatment Market Size by Application (2016-2021)
6.3.2 North America Endometriosis Treatment Market Size by Application (2022-2027)
6.3.3 North America Endometriosis Treatment Market Size by Application (2016-2027)
6.4 North America Endometriosis Treatment Market Size by Country
6.4.1 North America Endometriosis Treatment Market Size by Country (2016-2021)
6.4.2 North America Endometriosis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Endometriosis Treatment Market Size (2016-2027)
7.2 Europe Endometriosis Treatment Market Size by Type
7.2.1 Europe Endometriosis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Endometriosis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Endometriosis Treatment Market Size by Type (2016-2027)
7.3 Europe Endometriosis Treatment Market Size by Application
7.3.1 Europe Endometriosis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Endometriosis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Endometriosis Treatment Market Size by Application (2016-2027)
7.4 Europe Endometriosis Treatment Market Size by Country
7.4.1 Europe Endometriosis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Endometriosis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Endometriosis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Endometriosis Treatment Market Size by Type
8.2.1 Asia-Pacific Endometriosis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Endometriosis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Endometriosis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Endometriosis Treatment Market Size by Application
8.3.1 Asia-Pacific Endometriosis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Endometriosis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Endometriosis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Endometriosis Treatment Market Size by Region
8.4.1 Asia-Pacific Endometriosis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Endometriosis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Endometriosis Treatment Market Size (2016-2027)
9.2 Latin America Endometriosis Treatment Market Size by Type
9.2.1 Latin America Endometriosis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Endometriosis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Endometriosis Treatment Market Size by Type (2016-2027)
9.3 Latin America Endometriosis Treatment Market Size by Application
9.3.1 Latin America Endometriosis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Endometriosis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Endometriosis Treatment Market Size by Application (2016-2027)
9.4 Latin America Endometriosis Treatment Market Size by Country
9.4.1 Latin America Endometriosis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Endometriosis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Endometriosis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Endometriosis Treatment Market Size by Type
10.2.1 Middle East & Africa Endometriosis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Endometriosis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Endometriosis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Endometriosis Treatment Market Size by Application
10.3.1 Middle East & Africa Endometriosis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Endometriosis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Endometriosis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Endometriosis Treatment Market Size by Country
10.4.1 Middle East & Africa Endometriosis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Endometriosis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Endometriosis Treatment Introduction
11.1.4 AbbVie Revenue in Endometriosis Treatment Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Endometriosis Treatment Introduction
11.2.4 Eli Lilly Revenue in Endometriosis Treatment Business (2016-2021)
11.2.5 Eli Lilly Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Endometriosis Treatment Introduction
11.3.4 AstraZeneca Revenue in Endometriosis Treatment Business (2016-2021)
11.3.5 AstraZeneca Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Endometriosis Treatment Introduction
11.4.4 Bayer Revenue in Endometriosis Treatment Business (2016-2021)
11.4.5 Bayer Recent Development
11.5 Astellas Pharma
11.5.1 Astellas Pharma Company Details
11.5.2 Astellas Pharma Business Overview
11.5.3 Astellas Pharma Endometriosis Treatment Introduction
11.5.4 Astellas Pharma Revenue in Endometriosis Treatment Business (2016-2021)
11.5.5 Astellas Pharma Recent Development
11.6 Meditrina Pharmaceuticals
11.6.1 Meditrina Pharmaceuticals Company Details
11.6.2 Meditrina Pharmaceuticals Business Overview
11.6.3 Meditrina Pharmaceuticals Endometriosis Treatment Introduction
11.6.4 Meditrina Pharmaceuticals Revenue in Endometriosis Treatment Business (2016-2021)
11.6.5 Meditrina Pharmaceuticals Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Endometriosis Treatment Introduction
11.7.4 Pfizer Revenue in Endometriosis Treatment Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 Neurocrine Biosciences
11.8.1 Neurocrine Biosciences Company Details
11.8.2 Neurocrine Biosciences Business Overview
11.8.3 Neurocrine Biosciences Endometriosis Treatment Introduction
11.8.4 Neurocrine Biosciences Revenue in Endometriosis Treatment Business (2016-2021)
11.8.5 Neurocrine Biosciences Recent Development
11.9 Takeda Pharmaceutical
11.9.1 Takeda Pharmaceutical Company Details
11.9.2 Takeda Pharmaceutical Business Overview
11.9.3 Takeda Pharmaceutical Endometriosis Treatment Introduction
11.9.4 Takeda Pharmaceutical Revenue in Endometriosis Treatment Business (2016-2021)
11.9.5 Takeda Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Endometriosis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Hormonal Contraceptives
Table 3. Key Players of Gonadotropin-releasingHormone(Gn-RH)Agonists
Table 4. Key Players of Progestin Therapy
Table 5. Key Players of Aromatase Inhibitors
Table 6. Global Endometriosis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Endometriosis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Endometriosis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Endometriosis Treatment Market Share by Regions (2016-2021)
Table 10. Global Endometriosis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Endometriosis Treatment Market Share by Regions (2022-2027)
Table 12. Endometriosis Treatment Market Trends
Table 13. Endometriosis Treatment Market Drivers
Table 14. Endometriosis Treatment Market Challenges
Table 15. Endometriosis Treatment Market Restraints
Table 16. Global Endometriosis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Endometriosis Treatment Market Share by Players (2016-2021)
Table 18. Global Top Endometriosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endometriosis Treatment as of 2020)
Table 19. Ranking of Global Top Endometriosis Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Endometriosis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Endometriosis Treatment Product Solution and Service
Table 23. Date of Enter into Endometriosis Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Endometriosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Endometriosis Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Endometriosis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Endometriosis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Endometriosis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Endometriosis Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Endometriosis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Endometriosis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Endometriosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Endometriosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Endometriosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Endometriosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Endometriosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Endometriosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Endometriosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Endometriosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Endometriosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Endometriosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Endometriosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Endometriosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Endometriosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Endometriosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Endometriosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Endometriosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Endometriosis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Endometriosis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Endometriosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Endometriosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Endometriosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Endometriosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Endometriosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Endometriosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Endometriosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Endometriosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Endometriosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Endometriosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Endometriosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Endometriosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. AbbVie Company Details
Table 64. AbbVie Business Overview
Table 65. AbbVie Endometriosis Treatment Product
Table 66. AbbVie Revenue in Endometriosis Treatment Business (2016-2021) & (US$ Million)
Table 67. AbbVie Recent Development
Table 68. Eli Lilly Company Details
Table 69. Eli Lilly Business Overview
Table 70. Eli Lilly Endometriosis Treatment Product
Table 71. Eli Lilly Revenue in Endometriosis Treatment Business (2016-2021) & (US$ Million)
Table 72. Eli Lilly Recent Development
Table 73. AstraZeneca Company Details
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca Endometriosis Treatment Product
Table 76. AstraZeneca Revenue in Endometriosis Treatment Business (2016-2021) & (US$ Million)
Table 77. AstraZeneca Recent Development
Table 78. Bayer Company Details
Table 79. Bayer Business Overview
Table 80. Bayer Endometriosis Treatment Product
Table 81. Bayer Revenue in Endometriosis Treatment Business (2016-2021) & (US$ Million)
Table 82. Bayer Recent Development
Table 83. Astellas Pharma Company Details
Table 84. Astellas Pharma Business Overview
Table 85. Astellas Pharma Endometriosis Treatment Product
Table 86. Astellas Pharma Revenue in Endometriosis Treatment Business (2016-2021) & (US$ Million)
Table 87. Astellas Pharma Recent Development
Table 88. Meditrina Pharmaceuticals Company Details
Table 89. Meditrina Pharmaceuticals Business Overview
Table 90. Meditrina Pharmaceuticals Endometriosis Treatment Product
Table 91. Meditrina Pharmaceuticals Revenue in Endometriosis Treatment Business (2016-2021) & (US$ Million)
Table 92. Meditrina Pharmaceuticals Recent Development
Table 93. Pfizer Company Details
Table 94. Pfizer Business Overview
Table 95. Pfizer Endometriosis Treatment Product
Table 96. Pfizer Revenue in Endometriosis Treatment Business (2016-2021) & (US$ Million)
Table 97. Pfizer Recent Development
Table 98. Neurocrine Biosciences Company Details
Table 99. Neurocrine Biosciences Business Overview
Table 100. Neurocrine Biosciences Revenue in Endometriosis Treatment Business (2016-2021) & (US$ Million)
Table 101. Neurocrine Biosciences Recent Development
Table 102. Takeda Pharmaceutical Company Details
Table 103. Takeda Pharmaceutical Business Overview
Table 104. Takeda Pharmaceutical Endometriosis Treatment Product
Table 105. Takeda Pharmaceutical Revenue in Endometriosis Treatment Business (2016-2021) & (US$ Million)
Table 106. Takeda Pharmaceutical Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Endometriosis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Hormonal Contraceptives Features
Figure 3. Gonadotropin-releasingHormone(Gn-RH)Agonists Features
Figure 4. Progestin Therapy Features
Figure 5. Aromatase Inhibitors Features
Figure 6. Global Endometriosis Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Endometriosis Treatment Report Years Considered
Figure 11. Global Endometriosis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Endometriosis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Endometriosis Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Endometriosis Treatment Market Share by Regions (2022-2027)
Figure 15. Global Endometriosis Treatment Market Share by Players in 2020
Figure 16. Global Top Endometriosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endometriosis Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Endometriosis Treatment Revenue in 2020
Figure 18. Global Endometriosis Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Endometriosis Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Endometriosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Endometriosis Treatment Market Share by Type (2016-2027)
Figure 22. North America Endometriosis Treatment Market Share by Application (2016-2027)
Figure 23. North America Endometriosis Treatment Market Share by Country (2016-2027)
Figure 24. United States Endometriosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Endometriosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Endometriosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Endometriosis Treatment Market Share by Type (2016-2027)
Figure 28. Europe Endometriosis Treatment Market Share by Application (2016-2027)
Figure 29. Europe Endometriosis Treatment Market Share by Country (2016-2027)
Figure 30. Germany Endometriosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Endometriosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Endometriosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Endometriosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Endometriosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Endometriosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Endometriosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Endometriosis Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Endometriosis Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Endometriosis Treatment Market Share by Region (2016-2027)
Figure 40. China Endometriosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Endometriosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Endometriosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Endometriosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Endometriosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Endometriosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Endometriosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Endometriosis Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Endometriosis Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Endometriosis Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Endometriosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Endometriosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Endometriosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Endometriosis Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Endometriosis Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Endometriosis Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Endometriosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Endometriosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Endometriosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. AbbVie Revenue Growth Rate in Endometriosis Treatment Business (2016-2021)
Figure 60. Eli Lilly Revenue Growth Rate in Endometriosis Treatment Business (2016-2021)
Figure 61. AstraZeneca Revenue Growth Rate in Endometriosis Treatment Business (2016-2021)
Figure 62. Bayer Revenue Growth Rate in Endometriosis Treatment Business (2016-2021)
Figure 63. Astellas Pharma Revenue Growth Rate in Endometriosis Treatment Business (2016-2021)
Figure 64. Meditrina Pharmaceuticals Revenue Growth Rate in Endometriosis Treatment Business (2016-2021)
Figure 65. Pfizer Revenue Growth Rate in Endometriosis Treatment Business (2016-2021)
Figure 66. Neurocrine Biosciences Revenue Growth Rate in Endometriosis Treatment Business (2016-2021)
Figure 67. Takeda Pharmaceutical Revenue Growth Rate in Endometriosis Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

世界の子宮内膜症治療市場規模・現状・予測（2021年-2027年）

Global Endometriosis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2159 2021年4月 90Pages
QYResearch社発行の本調査資料では、子宮内膜症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ホルモン避妊薬、ゴナドトロピン放出ホルモン（Gn-RH）アゴニスト、プロゲスチン療法、アロマターゼ阻害剤）、用途別市場規模（病院、クリニッ...

世界の子宮内膜症治療市場規模・現状・予測（2021年-2027年）

Global Endometriosis Therapies Market Size, Status and Forecast 2021-2027
QYR2104Z2158 2021年4月 92Pages
QYResearch社発行の本調査資料では、子宮内膜症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ホルモン避妊薬、ゴナドトロピン放出ホルモン（Gn-RH）アゴニスト、プロゲスチン療法、アロマターゼ阻害剤）、用途別市場規模（病院、クリニッ...

世界の子宮内膜症治療薬市場規模・現状・予測（2021年-2027年）

Global Endometriosis Drugs Market Size, Status and Forecast 2021-2027
QYR2104Z2157 2021年4月 95Pages
QYResearch社発行の本調査資料では、子宮内膜症治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ホルモン療法、アドバック薬、プロゲストーゲン、漢方薬）、用途別市場規模（病院、クリニック、研究所）、主要地域別市場規模（北米、アメリカ、...

世界のスウェーデンポルフィリン症治療市場規模・現状・予測（2021年-2027年）

Global Swedish Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5520 2021年4月 99Pages
QYResearch社発行の本調査資料では、スウェーデンポルフィリン症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の後天性血友病A治療市場規模・現状・予測（2021年-2027年）

Global Acquired hemophilia A Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0029 2021年4月 97Pages
QYResearch社発行の本調査資料では、後天性血友病A治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（200IU、250IU）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、イン...

世界の急性間欠性ポルフィリン症（AIP）治療市場規模・現状・予測（2021年-2027年）

Global Acute Intermittent Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0060 2021年4月 92Pages
QYResearch社発行の本調査資料では、急性間欠性ポルフィリン症（AIP）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界のMSD治療市場規模・現状・予測（2021年-2027年）

Global MSD Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3939 2021年4月 91Pages
QYResearch社発行の本調査資料では、MSD治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx薬）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジ...

世界のアデノシンデアミナーゼ欠損症（ADA）治療市場規模・現状・予測（2021年-2027年）

Global Adenosine Deaminase Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0096 2021年4月 96Pages
QYResearch社発行の本調査資料では、アデノシンデアミナーゼ欠損症（ADA）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アダーゲン、レブコビ）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、...

世界の軟骨無形成症治療市場規模・現状・予測（2021年-2027年）

Global Achondroplasia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0013 2021年4月 92Pages
QYResearch社発行の本調査資料では、軟骨無形成症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（RBM-007、TA-46、B-701、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロ...

世界の神経芽細胞腫治療市場規模・現状・予測（2021年-2027年）

Global Neuroblastoma Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4085 2021年4月 90Pages
QYResearch社発行の本調査資料では、神経芽細胞腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（併用化学療法、モノクローナル抗体療法、ワクチン療法、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ...

世界の子宮内膜症治療市場規模・現状・予測（2021年-2027年） Therapies used to treat endometriosis include: Hormonal contraceptives. Birth control pills, patches and vaginal rings help control the hormones responsible for the buildup of endometrialtissue each month Market Analysis and Insights: Global Endometriosis Treatment Market The global Endometriosis Tr…
世界の子宮内膜症治療市場規模・現状・予測（2021年-2027年） Therapies used to treat endometriosis include: Hormonal contraceptives. Birth control pills, patches and vaginal rings help control the hormones responsible for the buildup of endometrialtissue each month Market Analysis and Insights: Global Endometriosis Therapies Market The global Endometriosis Th…
世界の子宮内膜症治療薬市場規模・現状・予測（2021年-2027年） Endometriosis affects an estimated 1 in 10 women in the reproductive age group of 15-49 years. Among these therapies, Elagolix, a first-in-class GnRH receptor antagonist, is closest to market. Market Analysis and Insights: Global Endometriosis Drugs Market The global Endometriosis Drugs market size …
世界の多嚢胞性卵巣症候群治療市場規模・現状・予測（2021年-2027年） Polycystic ovary syndrome is a set of symptoms due to elevated androgens in females. Signs and symptoms of polycystic ovary syndrome nclude irregular or no menstrual periods, heavy periods, excess body and facial hair, acne, pelvic pain, difficulty getting pregnant and patches of thick, darker, velv…
世界のうつ病治療用療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Depression Treatment Therapy Market The global Depression Treatment Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integri…